The relationship between ADHD and brain chemistry is complicated. Most discussions centre on dopamine and norepinephrine — the neurotransmitters that medication targets. But there is a growing body of research pointing to something quieter also at play: neuroinflammation and oxidative stress. These two forces can impair the brain's ability to focus, regulate impulse, and sustain attention — and they are exactly what certain medicinal mushrooms have evolved to address.
Two mushrooms in particular are attracting serious scientific attention in the ADHD conversation: Lion's Mane (Hericium erinaceus) and Chaga (Inonotus obliquus). They work on different aspects of the same problem. Lion's Mane targets neuroplasticity — the brain's ability to form and maintain neural connections. Chaga targets the oxidative and inflammatory environment that makes those connections harder to sustain. Together, they address parts of ADHD management that pharmaceuticals don't.
What's Actually Happening in the ADHD Brain
ADHD is not simply a deficit of willpower or attention. It is a neurological condition characterised by differences in dopaminergic and noradrenergic signalling — but increasingly, researchers recognise that neuroinflammation plays a compounding role. Elevated levels of pro-inflammatory cytokines including IL-6, TNF-α, and IL-1β have been observed in individuals with ADHD, and these markers correlate with the severity of inattention and impulsivity symptoms. When the brain is inflamed, its capacity to transmit signals cleanly — and to form the stable neural networks required for sustained focus — is compromised.
Oxidative stress compounds the problem. The brain consumes roughly 20% of the body's total oxygen while representing only 2% of body weight. This disproportionate energy demand makes the brain especially vulnerable to reactive oxygen species (free radicals). When antioxidant defences are depleted — by chronic stress, poor sleep, hormonal changes, or environmental toxins — neurons suffer damage, neurotransmitter production slows, and focus becomes effortful.
Lion's Mane — The NGF Stimulator
Lion's Mane's most important contribution to cognitive science is its ability to stimulate Nerve Growth Factor (NGF), a protein critical to the growth, maintenance, and repair of neurons. Two bioactive compounds — hericenones (in the fruiting body) and erinacines (in the mycelium) — are potent NGF inducers. NGF does not simply build neurons; it promotes the synaptic plasticity that underlies flexible, focused thinking.
In a landmark double-blind, placebo-controlled clinical trial (Mori et al., 2009, Phytotherapy Research), 30 adults aged 50–80 with mild cognitive impairment were given either 3 grams per day of Lion's Mane or a placebo for 16 weeks. Those taking Lion's Mane showed significantly higher cognitive function scores at weeks 8, 12, and 16 compared to the placebo group. Crucially, scores declined after supplementation stopped — suggesting effects are cumulative and require continued use, a meaningful point for anyone considering Lion's Mane as part of an ongoing ADHD support protocol.
A research protocol published in the URNCST Journal (2024) explored Lion's Mane's cognitive-enhancing effects in a rodent ADHD model specifically, identifying the mushroom's potential to support attention and impulse control via NGF-mediated pathways. A separate 2025 study (PMC11822522) found Lion's Mane phytoconstituents may directly target SLC6A4 — the gene encoding the serotonin transporter implicated in ADHD symptomology — adding a serotonergic dimension to the more commonly discussed dopaminergic picture.
Chaga — Clearing the Neuroinflammatory Smoke
If Lion's Mane is building the brain's wiring, Chaga is clearing the smoke that makes it hard to think through. Chaga holds one of the highest Oxygen Radical Absorbance Capacity (ORAC) values of any natural food tested. Its key compounds — inotodiol, betulinic acid, polyphenols, and ergothioneine — collectively target the oxidative and inflammatory environment that exacerbates ADHD symptoms.
Research published in the International Journal of Molecular Sciences (PMC12111798, 2025) found that INO10, an inotodiol-rich Chaga extract, significantly reduced the expression of pro-inflammatory cytokines — IL-1β, IL-6, and TNF-α — in brain immune cells. These are the precise markers most consistently linked to ADHD severity. The same study found that oral administration of INO10 improved spatial memory in Alzheimer's model mice, confirming that the anti-inflammatory mechanism produces measurable cognitive benefit.
Chaga also upregulates the Nrf2 pathway — the body's master antioxidant switch. Nrf2 activation triggers endogenous production of protective compounds including glutathione and superoxide dismutase, creating a brain environment that is far better defended against the ongoing oxidative damage that disrupts focus and mental consistency.
A Complementary, Not Competing, Approach
It is worth being clear about what mushrooms can and cannot do for ADHD. They are not replacements for medication where medication is clinically indicated and working well. But they address biological mechanisms that medication does not — specifically, the underlying inflammatory and oxidative landscape that makes ADHD symptoms harder to manage. For those who want to complement their existing treatment, or who are exploring non-pharmaceutical support, Lion's Mane and Chaga offer a compelling, evidence-backed starting point.
Both mushrooms are non-stimulating, well-tolerated, and build their effects cumulatively. What they share is a commitment to the environment in which neurons live and work — because a brain that is nourished, protected, and not fighting its own inflammation is a brain that can focus.
References
1. Mori, K., Inatomi, S., Ouchi, K., Azumi, Y., & Inamura, T. (2009). Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research, 23(3), 367-372. https://doi.org/10.1002/ptr.2634
2. Phytoconstituents of Hericium erinaceus exert benefits for ADHD conditions by targeting SLC6A4 (2025). PubMed Central, PMC11822522. https://pmc.ncbi.nlm.nih.gov/articles/PMC11822522/
3. The Cognitive-Enhancing Effects of Lion's Mane in a Rodent Model of ADHD: A Research Protocol (2024). Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal. https://www.urncst.com/index.php/urncst/article/view/653
4. INO10, a Chaga Mushroom Extract, Alleviates Alzheimer's Disease-Related Pathology and Cognitive Deficits in 3xTg-AD Mice (2025). International Journal of Molecular Sciences, 26(10), 4729. PMC12111798. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12111798/
5. Isolation, Physicochemical Characterization, and Biological Properties of Inotodiol, the Potent Pharmaceutical Oxysterol from Chaga Mushroom (2023). PubMed Central, PMC9952744. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952744/